Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.
Stocktwits on MSN
Eli Lilly And Novo Nordisk Ignite Bullish Retail Frenzy Ahead Of TrumpRx Deals To Slash Prices For Weight-Loss Drugs
Eli Lilly and Novo Nordisk are expected to announce price reductions for their weight-loss drugs as part of the TrumpRx ...
Tokyo's benchmark Nikkei 225 index has fallen more than 4% and other shares in Asia also sank after a retreat on Wall Street ...
The Manila Times on MSN
Stocks mostly drop as tech rally fades
Global stocks mostly fell Tuesday as investors weighed the recent tech rally on Wall Street against growing fears of an AI bubble and concerns over the US interest-rate outlook.
The bidding war over biotechnology company Metsera (MTSR) has intensified, drawing fierce competition from pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback